IP Library › Granted Patent US 8,927,277
Granted Patent B2
US 8,927,277 · App. 13/579,234 · Granted Jan 6, 2015

Method of efficiently establishing induced pluripotent stem cells

Inventors: Shinya Yamanaka (Kyoto, JP); Naoki Goshima (Tokyo, JP); Momoko Maekawa (Kyoto, JP); Yoshifumi Kawamura (Tokyo, JP); Hiromi Mochizuki (Tokyo, JP)
Assignees: Kyoto University; National Institute of Advanced Industrial Science and Technology; Japan Biological Informatics Consortium
C12N5/0696C12N2501/60C12N2501/602C12N2501/603C12N2501/604C12N2510/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,927,277
App. No.
13/579,234
Granted
Jan 6, 2015
Kind
B2
Abstract

Provided are a method of improving the efficiency of establishment of iPS cells, comprising the step of contacting one or more substances selected from the group consisting of members of the GLIS family (e.g., GLIS1) and nucleic acids that encode the same and one or more substances selected from the group consisting of members of the Klf family and nucleic acids that encode the same, with a somatic cell, an iPS cell comprising an exogenous nucleic acid that encodes a member of the GLIS family or a member of the Klf family, that can be obtained by the method, and a method of producing a somatic cell by inducing the differentiation of the iPS cell.

Claims (16)

1. A method of producing an iPS cell, comprising

culturing a somatic cell transfected with nucleic acids that encode the following (1), (2), (3), and (4):

(1) GLIS1,

(2) Oct3/4,

(3) a member of the Klf family selected from the group consisting of Klf1, Klf2, Klf4, and Klf5,

(4) a member of the Sox family selected from the group consisting of Sox1, Sox2, Sox3, Sox15, and Sox17,

thereby producing an iPS cell.

2. The method according to claim 1 , wherein the member of the Klf family is Klf4.

3. The method according to claim 1 , wherein the somatic cell has been transfected with a further nucleic acid that encodes a reprogramming substance selected from the group consisting of a member of the Myc family, a member of the Lin28 family, and Nanog,

wherein the member of the Myc family is selected from the group consisting of c-Myc, L-Myc and N-Myc, and

wherein the member of the Lin28 family is selected from the group consisting of Lin28 and Lin28b.

4. The method according to claim 1 , wherein the member of the Sox family is Sox2.

5. The method according to claim 1 , wherein the member of the Myc family is c-Myc.

6. A method of producing a somatic cell, comprising the following (1) and (2):

(1) the step of producing an iPS cell by the method according to claim 1 , and

(2) the step of treating the iPS cell obtained through the step (1) above to induce it to differentiate into a somatic cell.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2012
From: YAMANAKA, SHINYA; GOSHIMA, NAOKI; MAEKAWA, MOMOKO; KAWAMURA, YOSHIFUMI; MOCHIZUKI, HIROMI
To: KYOTO UNIVERSITY; NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY; JAPAN BIOLOGICAL INFORMATICS CONSORTIUM
Reel/Frame 029071/0732 →
Continuity (3)
Provisional Application 61305107 · Feb 16, 2010
Provisional Application 61379949 · Sep 3, 2010
Related Publication 20130029423A1 · Jan 31, 2013